MicroRNA and NF-kappa B

Advances in Experimental Medicine and Biology

Volumn 887, Issue , 2015, Pages 157-170

  Yuan, Ye ^a   Tong, Lingying ^a   Wu, Shiyong ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Angiogenesis; Apoptosis; Cancer; Carcinogens; Cell cycle; NF B; Therapeutics

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; STAT3 PROTEIN;

CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; NEGATIVE FEEDBACK; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; APOPTOSIS; CELL CYCLE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; VASCULARIZATION;

ANIMALS; APOPTOSIS; CELL CYCLE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84949783310     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-22380-3_9     Document Type: Chapter

References (83)

1. Baldwin AS. Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest. 2001;107(1):3-6 Pubmed Central PMCID: 198555. Epub 2001/01/03. eng
2. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest. 2001;107(3):241-6 Pubmed Central PMCID: 199203. Epub 2001/02/13. eng
3. Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301-10 Epub 2002/05/11. eng
4. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3(3): 221-7 Epub 2002/03/05. eng
5. Grimm S, Baeuerle PA. The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J. 1993;290(Pt 2):297-308 Pubmed Central PMCID: 1132272
6. Dhawan P, Singh AB, Ellis DL, Richmond A. Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res. 2002;62(24):7335-42 Epub 2002/12/25. eng
7. Karin M. NF-kappaB as a critical link between infl ammation and cancer. Cold Spring Harb Perspect Biol. 2009;1(5):a000141 Pubmed Central PMCID: 2773649
8. Karin M, Greten FR. NF-kappaB: linking infl ammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749-59
9. Karin M. NF-kappaB and cancer: mechanisms and targets. Mol Carcinog. 2006;45(6):355-61
10. Sassen S, Miska EA, Caldas C. MicroRNA: implications for cancer. Virchows Arch. 2008;452(1):1-10 Pubmed Central PMCID: 2151131
11. Jiang L, Lin C, Song L, Wu J, Chen B, Ying Z, et al. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/ IkappaBalpha negative feedback loop. J Clin Invest. 2012;122(1):33-47 Pubmed Central PMCID: 3248293. Epub 2011/12/14. eng
12. Liu K, Zhao H, Yao H, Lei S, Lei Z, Li T, et al. MicroRNA-124 regulates the proliferation of colorectal cancer cells by targeting iASPP. BioMed Res Int. 2013;2013:867537 Pubmed Central PMCID: 3652105. Epub 2013/05/22. eng
13. Kim SW, Ramasamy K, Bouamar H, Lin AP, Jiang D, Aguiar RC. MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci U S A. 2012;109(20):7865-70 Pubmed Central PMCID: 3356650. Epub 2012/05/03. eng
14. Song L, Liu L, Wu Z, Li Y, Ying Z, Lin C, et al. TGF-beta induces miR-182 to sustain NF-kappaB activation in glioma subsets. J Clin Invest. 2012;122(10):3563-78 Pubmed Central PMCID: 3589141. Epub 2012/09/26. eng
15. Su JL, Chen PB, Chen YH, Chen SC, Chang YW, Jan YH, et al. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res. 2010;70(12):5096-108 Pubmed Central PMCID: 2891368. Epub 2010/05/27. eng
16. Korner C, Keklikoglou I, Bender C, Worner A, Munstermann E, Wiemann S. MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon). J Biol Chem. 2013;288(12):8750-61 Pubmed Central PMCID: 3605692. Epub 2013/02/01. eng
17. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, et al. Polycombmediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell. 2012;21(1):121-35 Epub 2012/01/24. eng
18. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008;27(42):5643-7 Pubmed Central PMCID: 2811234. Epub 2008/05/28. eng
19. Li X, Xu B, Moran MS, Zhao Y, Su P, Haffty BG, et al. 53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-kappaB through miR-146a. Carcinogenesis. 2012;33(12):2593-600 Epub 2012/10/03. eng
20. Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH, et al. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012;11:71 Pubmed Central PMCID: 3515505. Epub 2012/09/21. eng
21. Li Y, Vandenboom 2nd TG, Wang Z, Kong D, Ali S, Philip PA, et al. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 2010;70(4):1486-95 Pubmed Central PMCID: 2978025. Epub 2010/02/04. eng
22. Hu N, Zhang J, Cui W, Kong G, Zhang S, Yue L, et al. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J Biol Chem. 2011;286(15):13714-22 Pubmed Central PMCID: 3075715. Epub 2011/02/24. eng
23. Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A, et al. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways. Oncogene. 2012;31(37):4150-63 Epub 2011/12/14. eng
24. Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK). Oncogene. 2012;31(31):3607-20 Epub 2011/11/23. eng
25. Ro S, Park C, Young D, Sanders KM, Yan W. Tissue-dependent paired expression of miRNAs. Nucleic Acids Res. 2007;35(17):5944-53 Pubmed Central PMCID: 2034466
26. Zhang B, Pan X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ Health Perspect. 2009;117(2):231-40 Pubmed Central PMCID: 2649225
27. Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003;424(6950):801-5
28. Li G, Wang R, Gao J, Deng K, Wei J, Wei Y. RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells. Mol Cell Biochem. 2011;350(1-2):193-200
29. Lin B, Williams-Skipp C, Tao Y, Schleicher MS, Cano LL, Duke RC, et al. NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 1999;6(6):570-82
30. Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009;30(8):383-91
31. Palkowitsch L, Leidner J, Ghosh S, Marienfeld RB. Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity. J Biol Chem. 2008;283(1):76-86
32. Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC, et al. Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res. 2003;63(2): 290-5
33. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481-6 Pubmed Central PMCID: 1567904
34. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499-511
35. Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, et al. MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res. 2011;17(14):4761-71 Epub 2011/05/26. eng
36. Zhao JL, Rao DS, Boldin MP, Taganov KD, O’Connell RM, Baltimore D. NF-kappaB dysregulation in microRNA-146a-defi cient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A. 2011;108(22):9184-9 Pubmed Central PMCID: 3107319. Epub 2011/05/18. eng
37. Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, Feng J, et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol. 2010;25(1):164-71
38. Cui W, Zhang Y, Hu N, Shan C, Zhang S, Zhang W, et al. miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3′UTR of CD46. Cancer Biol Ther. 2010;10(3):232-41
39. Shin VY, Jin H, Ng EK, Cheng AS, Chong WW, Wong CY, et al. NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis. 2011;32(2):240-5 Epub 2010/11/18. eng
40. Duan Q, Wang X, Gong W, Ni L, Chen C, He X, et al. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One. 2012;7(2):e31518 Pubmed Central PMCID: 3281082. Epub 2012/02/24. eng
41. Scisciani C, Vossio S, Guerrieri F, Schinzari V, De Iaco R, D Onorio de Meo P, et al. Transcriptional regulation of miR-224 upregulated in human HCCs by NFkappaB infl ammatory pathways. J Hepatol. 2012;56(4):855-61 Epub 2011/12/20. eng
42. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking infl ammation to cancer. Mol Cell. 2010;39(4):493-506 Pubmed Central PMCID: 2929389. Epub 2010/08/28. eng
43. Bakirtzi K, Hatziapostolou M, Karagiannides I, Polytarchou C, Jaeger S, Iliopoulos D, et al. Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors. Gastroenterology. 2011;141(5):1749-61 e1 Epub 2011/08/03. eng
44. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005;207(2):243-9
45. Rahadiani N, Takakuwa T, Tresnasari K, Morii E, Aozasa K. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem Biophys Res Commun. 2008;377(2): 579-83 Epub 2008/10/18. eng
46. Pu J, Bai D, Yang X, Lu X, Xu L, Lu J. Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155. Biochem Biophys Res Commun. 2012;428(2):210-5 Epub 2012/10/06. eng
47. Zhou P, Jiang W, Wu L, Chang R, Wu K, Wang Z. miR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma. Dig Dis Sci. 2012;57(5):1171-80 Epub 2012/03/01. eng
48. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, et al. Expression profi ling identifi es microRNA signature in pancreatic cancer. Int J Cancer. 2007;120(5):1046-54 Pubmed Central PMCID: 2680248
49. Lu Z, Li Y, Takwi A, Li B, Zhang J, Conklin DJ, et al. miR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J. 2011;30(1):57-67 Pubmed Central PMCID: 3020116. Epub 2010/11/30. eng
50. Wu J, Ji X, Zhu L, Jiang Q, Wen Z, Xu S, et al. Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. Cancer Lett. 2013;329(2):155-63 Epub 2012/11/13. eng
51. Rokavec M, Wu W, Luo JL. IL6-mediated suppression of miR-200c directs constitutive activation of infl ammatory signaling circuit driving transformation and tumorigenesis. Mol Cell. 2012;45(6):777-89 Pubmed Central PMCID: 3319241. Epub 2012/03/01. eng
52. Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen YY, et al. Involvement of NF-kappaB/miR- 448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ. 2011;18(1):16-25 Pubmed Central PMCID: 3131865. Epub 2010/08/28. eng
53. Arora H, Qureshi R, Jin S, Park AK, Park WY. miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1. Exp Mol Med. 2011;43(5):298-304 Pubmed Central PMCID: 3104252. Epub 2011/04/06. eng
54. Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer. 2010;9:16 Pubmed Central PMCID: 2835654. Epub 2010/01/28. eng
55. Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, et al. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J. 2009;276(19):5537-46 Epub 2009/08/26. eng
56. Janssens S, Tinel A, Lippens S, Tschopp J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell. 2005;123(6):1079-92
57. Wang J, Gu Z, Ni P, Qiao Y, Chen C, Liu X, et al. NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with microRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop. Nucleic Acids Res. 2011;39(15):6440-55 Pubmed Central PMCID: 3159468. Epub 2011/05/17. eng
58. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links infl ammation to cell transformation. Cell. 2009;139(4):693-706 Pubmed Central PMCID: 2783826. Epub 2009/11/03. eng
59. Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, Morozov P, et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 2011;71(13):4443-53 Pubmed Central PMCID: 3129492
60. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14(11):2348-60 Pubmed Central PMCID: 2578865
61. Niu J, Shi Y, Tan G, Yang CH, Fan M, Pfeffer LM, et al. DNA damage induces NF-kappaBdependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem. 2012;287(26):21783-95 Pubmed Central PMCID: 3381141. Epub 2012/05/02. eng
62. Barbarotto E, Schmittgen TD, Calin GA. MicroRNAs and cancer: profi le, profi le, profi le. Int J Cancer. 2008;122(5):969-77
63. Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet. 2008;181(1):8-15 Pubmed Central PMCID: 2276854. Epub 2008/02/12. eng
64. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964;1(7335):702-3
65. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med. 1989;320(8):502-6
66. Kluiver J, van den Berg A, de Jong D, Blokzijl T, Harms G, Bouwman E, et al. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene. 2007;26(26):3769-76 Epub 2006/12/19. eng
67. Koon HW, Kim YS, Xu H, Kumar A, Zhao D, Karagiannides I, et al. Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis. Proc Natl Acad Sci U S A. 2009;106(21):8766-71 Pubmed Central PMCID: 2688970
68. Maoret JJ, Anini Y, Rouyer-Fessard C, Gully D, Laburthe M. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer. 1999;80(3):448-54
69. Patel S, Leal AD, Gorski DH. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression. Cancer Res. 2005;65(4):1414-24
70. Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S, et al. Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res. 2011;71(4):1497-505 Pubmed Central PMCID: 3079548
71. Luscan A, Shackleford G, Masliah-Planchon J, Laurendeau I, Ortonne N, Varin J, et al. The activation of the WNT signalling pathway is a hallmark in neurofi bromatosis type 1 tumorigenesis. Clin Cancer Res. 2013;20(2):358-71
72. Luis TC, Naber BA, Roozen PP, Brugman MH, de Haas EF, Ghazvini M, et al. Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell. 2011;9(4):345-56
73. Hu X, Schwarz JK, Lewis Jr. JS, Huettner PC, Rader JS, Deasy JO, et al. A microRNA expression signature for cervical cancer prognosis. Cancer Res. 2010;70(4):1441-8 Pubmed Central PMCID: 2844247
74. Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, et al. Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics. 2011;6(10):1189-97 Pubmed Central PMCID: 3225840
75. Liu N, Sun Q, Chen J, Li J, Zeng Y, Zhai S, et al. MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-kappaB1 pathway. Oncol Rep. 2012;28(3):961-8 Epub 2012/07/25. eng
76. Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, et al. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-kappaB1-Snail1 pathway in melanoma. J Pathol. 2012;226(1):61-72 Epub 2011/12/02. eng
77. Ohneda O, Ohneda K, Arai F, Lee J, Miyamoto T, Fukushima Y, et al. ALCAM (CD166): its role in hematopoietic and endothelial development. Blood. 2001;98(7):2134-42
78. Borralho PM, Kren BT, Castro RE, da Silva IB, Steer CJ, Rodrigues CM. MicroRNA-143 reduces viability and increases sensitivity to 5-fl uorouracil in HCT116 human colorectal cancer cells. FEBS J. 2009;276(22):6689-700 Epub 2009/10/22. eng
79. Kim SY, Kim JC, Kim JK, Kim HJ, Lee HM, Choi MS, et al. Hepatitis B virus X protein enhances NFkappaB activity through cooperating with VBP1. BMB Rep. 2008;41(2):158-63
80. Su F, Schneider RJ. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol. 1996;70(7):4558-66 Pubmed Central PMCID: 190392
81. Yun C, Um HR, Jin YH, Wang JH, Lee MO, Park S, et al. NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Lett. 2002;184(1): 97-104
82. Zhang X, Liu S, Hu T, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fi bronectin expression. Hepatology. 2009;50(2):490-9 Epub 2009/05/28. eng
83. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117(7):927-39